Artificial intelligence in hepatocellular carcinoma diagnosis: a comprehensive review of current literature.
HCC
artificial intelligence
diagnosis
models
radiomics
Journal
Journal of gastroenterology and hepatology
ISSN: 1440-1746
Titre abrégé: J Gastroenterol Hepatol
Pays: Australia
ID NLM: 8607909
Informations de publication
Date de publication:
23 Jun 2024
23 Jun 2024
Historique:
revised:
26
04
2024
received:
05
09
2023
accepted:
07
06
2024
medline:
26
6
2024
pubmed:
26
6
2024
entrez:
26
6
2024
Statut:
aheadofprint
Résumé
Hepatocellular carcinoma (HCC) diagnosis mainly relies on its pathognomonic radiological profile, obviating the need for biopsy. The project of incorporating artificial intelligence (AI) techniques in HCC aims to improve the performance of image recognition. Herein, we thoroughly analyze and evaluate proposed AI models in the field of HCC diagnosis. A comprehensive review of the literature was performed utilizing MEDLINE/PubMed and Web of Science databases with the end of search date being the 30th of September 2023. The MESH terms "Artificial Intelligence," "Liver Cancer," "Hepatocellular Carcinoma," "Machine Learning," and "Deep Learning" were searched in the title and/or abstract. All references of the obtained articles were also evaluated for any additional information. Our search resulted in 183 studies meeting our inclusion criteria. Across all diagnostic modalities, reported area under the curve (AUC) of most developed models surpassed 0.900. A B-mode US and a contrast-enhanced US model achieved AUCs of 0.947 and 0.957, respectively. Regarding the more challenging task of HCC diagnosis, a 2021 deep learning model, trained with CT scans, classified hepatic malignant lesions with an AUC of 0.986. Finally, a MRI machine learning model developed in 2021 displayed an AUC of 0.975 when differentiating small HCCs from benign lesions, while another MRI-based model achieved HCC diagnosis with an AUC of 0.970. AI tools may lead to significant improvement in diagnostic management of HCC. Many models fared better or comparable to experienced radiologists while proving capable of elevating radiologists' accuracy, demonstrating promising results for AI implementation in HCC-related diagnostic tasks.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
Hepatocellular carcinoma (HCC) diagnosis mainly relies on its pathognomonic radiological profile, obviating the need for biopsy. The project of incorporating artificial intelligence (AI) techniques in HCC aims to improve the performance of image recognition. Herein, we thoroughly analyze and evaluate proposed AI models in the field of HCC diagnosis.
METHODS
METHODS
A comprehensive review of the literature was performed utilizing MEDLINE/PubMed and Web of Science databases with the end of search date being the 30th of September 2023. The MESH terms "Artificial Intelligence," "Liver Cancer," "Hepatocellular Carcinoma," "Machine Learning," and "Deep Learning" were searched in the title and/or abstract. All references of the obtained articles were also evaluated for any additional information.
RESULTS
RESULTS
Our search resulted in 183 studies meeting our inclusion criteria. Across all diagnostic modalities, reported area under the curve (AUC) of most developed models surpassed 0.900. A B-mode US and a contrast-enhanced US model achieved AUCs of 0.947 and 0.957, respectively. Regarding the more challenging task of HCC diagnosis, a 2021 deep learning model, trained with CT scans, classified hepatic malignant lesions with an AUC of 0.986. Finally, a MRI machine learning model developed in 2021 displayed an AUC of 0.975 when differentiating small HCCs from benign lesions, while another MRI-based model achieved HCC diagnosis with an AUC of 0.970.
CONCLUSIONS
CONCLUSIONS
AI tools may lead to significant improvement in diagnostic management of HCC. Many models fared better or comparable to experienced radiologists while proving capable of elevating radiologists' accuracy, demonstrating promising results for AI implementation in HCC-related diagnostic tasks.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Références
Pérez MJ, Grande RG. Application of artificial intelligence in the diagnosis and treatment of hepatocellular carcinoma: a review. World J. Gastroenterol. 2020; 26: 5617–5628. Available from: https://pubmed.ncbi.nlm.nih.gov/33088156/.
Moglia A, Georgiou K, Morelli L, Toutouzas K, Satava RM, Cuschieri A. Breaking down the silos of artificial intelligence in surgery: glossary of terms. Surg. Endosc. 2022.
Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018; 391: 1301–1314.
Mokrane FZ, Lu L, Vavasseur A et al. Radiomics machine‐learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules. Eur. Radiol. 2020; 30: 558–570. Available from: https://pubmed.ncbi.nlm.nih.gov/31444598/.
Galle PR, Forner A, Llovet JM et al. EASL clinical practice guidelines: management of hepatocellular carcinoma. J. Hepatol. 2018; 69: 182–236. Available from: https://pubmed.ncbi.nlm.nih.gov/29628281/.
Di Tommaso L, Spadaccini M, Donadon M, Personeni N, Elamin A, Aghemo A, Lleo A. Role of liver biopsy in hepatocellular carcinoma. World J. Gastroenterol. 2019; 25: 6041–6052. Available from: https://pubmed.ncbi.nlm.nih.gov/31686761/.
Hu R, Li H, Horng H et al. Automated machine learning for differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma on multiphasic MRI. Sci. Rep. 2022; 12. Available from: https://pubmed.ncbi.nlm.nih.gov/35562532/
Hu HT, Wang W, Da CL et al. Artificial intelligence assists identifying malignant versus benign liver lesions using contrast‐enhanced ultrasound. J. Gastroenterol. Hepatol. 2021; 36: 2875–2883. Available from: https://pubmed.ncbi.nlm.nih.gov/33880797/.
Cao LL, Peng M, Xie X et al. Artificial intelligence in liver ultrasound. World J. Gastroenterol. 2022; 28: 3398–3409. Available from: https://pubmed.ncbi.nlm.nih.gov/36158262/.
Oestmann PM, Wang CJ, Savic LJ et al. Deep learning‐assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non‐HCC on contrast‐enhanced MRI of the liver. Eur. Radiol. 2021; 31: 4981–4990. Available from: https://pubmed.ncbi.nlm.nih.gov/33409782/.
Yang Q, Wei J, Hao X et al. Improving B‐mode ultrasound diagnostic performance for focal liver lesions using deep learning: a multicentre study. EBioMedicine 2020; 56. Available from: https://pubmed.ncbi.nlm.nih.gov/32485640/.
Xi IL, Wu J, Guan J et al. Deep learning for differentiation of benign and malignant solid liver lesions on ultrasonography. Abdom. Radiol. (NY) 2021; 46: 534–543. Available from: https://pubmed.ncbi.nlm.nih.gov/32681268/.
Schmauch B, Herent P, Jehanno P et al. Diagnosis of focal liver lesions from ultrasound using deep learning. Diagn. Interv. Imaging 2019; 100: 227–233 Available from: https://pubmed.ncbi.nlm.nih.gov/30926443/.
Bin ZW, Hou SZ, Chen YL et al. Deep learning for approaching hepatocellular carcinoma ultrasound screening dilemma: identification of α‐fetoprotein‐negative hepatocellular carcinoma from focal liver lesion found in high‐risk patients. Front. Oncol. 2022; 12. Available from: https://pubmed.ncbi.nlm.nih.gov/35720017/.
Nishida N, Yamakawa M, Shiina T et al. Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts. J. Gastroenterol. 2022; 57: 309–321. Available from: https://pubmed.ncbi.nlm.nih.gov/35220490/.
Liu L, Tang C, Li L et al. Deep learning radiomics for focal liver lesions diagnosis on long‐range contrast‐enhanced ultrasound and clinical factors. Quant. Imaging Med. Surg. 2022; 12: 3213–3226 Available from: https://pubmed.ncbi.nlm.nih.gov/35655832/.
Turco S, Tiyarattanachai T, Ebrahimkheil K et al. Interpretable machine learning for characterization of focal liver lesions by contrast‐enhanced ultrasound. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 2022; 69: 1670–1681. Available from: https://pubmed.ncbi.nlm.nih.gov/35320099/.
Tiyarattanachai T, Apiparakoon T, Marukatat S et al. Development and validation of artificial intelligence to detect and diagnose liver lesions from ultrasound images. PLoS ONE 2021; 16. Available from: https://pubmed.ncbi.nlm.nih.gov/34101764/
Ryu H, Shin SY, Lee JY, Lee KM, Kang HJ, Yi J. Joint segmentation and classification of hepatic lesions in ultrasound images using deep learning. Eur. Radiol. 2021; 31: 8733–8742. Available from: https://pubmed.ncbi.nlm.nih.gov/33881566/.
Ren S, Li Q, Liu S et al. Clinical value of machine learning‐based ultrasomics in preoperative differentiation between hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a multicenter study. Front. Oncol. 2021; 11. Available from: https://pubmed.ncbi.nlm.nih.gov/34804935/.
Marya NB, Powers PD, Fujii‐Lau L et al. Application of artificial intelligence using a novel EUS‐based convolutional neural network model to identify and distinguish benign and malignant hepatic masses. Gastrointest. Endosc. 2021; 93: 1121–1130.e1. Available from: https://pubmed.ncbi.nlm.nih.gov/32861752/.
Li W, Lv XZ, Zheng X et al. Machine learning‐based ultrasomics improves the diagnostic performance in differentiating focal nodular hyperplasia and atypical hepatocellular carcinoma. Front. Oncol. 2021; 11. Available from: https://pubmed.ncbi.nlm.nih.gov/33842303/.
Căleanu CD, Sîrbu CL, Simion G. Deep neural architectures for contrast enhanced ultrasound (CEUS) focal liver lesions automated diagnosis. Sensors (Basel) 2021; 21(12). Available from: https://pubmed.ncbi.nlm.nih.gov/34208548/.
Huang Q, Pan F, Li W et al. Differential diagnosis of atypical hepatocellular carcinoma in contrast‐enhanced ultrasound using spatio‐temporal diagnostic semantics. IEEE J. Biomed. Health Inform. 2020; 24: 2860–2869.
Guo LH, Wang D, Qian YY et al. A two‐stage multi‐view learning framework based computer‐aided diagnosis of liver tumors with contrast enhanced ultrasound images. Clin. Hemorheol. Microcirc. 2018; 69: 343–354. Available from: https://pubmed.ncbi.nlm.nih.gov/29630528/.
Bharti P, Mittal D, Ananthasivan R. Preliminary study of chronic liver classification on ultrasound images using an ensemble model. Ultrason. Imaging 2018; 40: 357–379. Available from: https://pubmed.ncbi.nlm.nih.gov/30015593/.
Hassan TM, Elmogy M, Sallam ES. Diagnosis of focal liver diseases based on deep learning technique for ultrasound images. Arab. J. Sci. Eng. 2017; 42: 3127–3140.
Kondo S, Takagi K, Nishida M et al. Computer‐aided diagnosis of focal liver lesions using contrast‐enhanced ultrasonography with perflubutane microbubbles. IEEE Trans. Med. Imaging 2017; 36: 1427–1437. Available from: https://pubmed.ncbi.nlm.nih.gov/28141517/.
Wang M, Fu F, Zheng B et al. Development of an AI system for accurately diagnose hepatocellular carcinoma from computed tomography imaging data. Br. J. Cancer 2021; 125: 1111–1121. Available from: https://pubmed.ncbi.nlm.nih.gov/34365472/.
Kim DW, Lee G, Kim SY et al. Deep learning‐based algorithm to detect primary hepatic malignancy in multiphase CT of patients at high risk for HCC. Eur. Radiol. 2021; 31: 7047–7057. Available from: https://pubmed.ncbi.nlm.nih.gov/33738600/.
Gao R, Zhao S, Aishanjiang K et al. Deep learning for differential diagnosis of malignant hepatic tumors based on multi‐phase contrast‐enhanced CT and clinical data. J. Hematol. Oncol. 2021; 14. Available from: https://pubmed.ncbi.nlm.nih.gov/34565412/.
Yang CJ, Wang CK, Dean Fang YH et al. Clinical application of mask region‐based convolutional neural network for the automatic detection and segmentation of abnormal liver density based on hepatocellular carcinoma computed tomography datasets. PLoS ONE 2021; 16. Available from: https://pubmed.ncbi.nlm.nih.gov/34375365/: e0255605.
Nakai H, Fujimoto K, Yamashita R et al. Convolutional neural network for classifying primary liver cancer based on triple‐phase CT and tumor marker information: a pilot study. Jpn. J. Radiol. 2021; 39: 690–702. Available from: https://pubmed.ncbi.nlm.nih.gov/33689107/.
Shi W, Kuang S, Cao S et al. Deep learning assisted differentiation of hepatocellular carcinoma from focal liver lesions: choice of four‐phase and three‐phase CT imaging protocol. Abdom. Radiol. (NY) 2020; 45: 2688–2697. Available from: https://pubmed.ncbi.nlm.nih.gov/32232524/.
Cao SE, Zhang LQ, Kuang SC et al. Multiphase convolutional dense network for the classification of focal liver lesions on dynamic contrast‐enhanced computed tomography. World J. Gastroenterol. 2020; 26: 3660–3672. Available from: https://pubmed.ncbi.nlm.nih.gov/32742134/.
Yasaka K, Akai H, Abe O, Kiryu S. Deep learning with convolutional neural network for differentiation of liver masses at dynamic contrast‐enhanced CT: a preliminary study. Radiology 2018; 286: 887–896. Available from: https://pubmed.ncbi.nlm.nih.gov/29059036/.
Kim J, Min JH, Kim SK, Shin SY, Lee MW. Detection of hepatocellular carcinoma in contrast‐enhanced magnetic resonance imaging using deep learning classifier: a multi‐center retrospective study. Sci. Rep. 2020; 10. Available from: https://pubmed.ncbi.nlm.nih.gov/32527998/
Bousabarah K, Letzen B, Tefera J et al. Automated detection and delineation of hepatocellular carcinoma on multiphasic contrast‐enhanced MRI using deep learning. Abdom. Radiol. (NY) 2021; 46: 216–225. Available from: https://pubmed.ncbi.nlm.nih.gov/32500237/.
Sun K, Shi L, Qiu J, Pan Y, Wang X, Wang H. Multi‐phase contrast‐enhanced magnetic resonance image‐based radiomics‐combined machine learning reveals microscopic ultra‐early hepatocellular carcinoma lesions. Eur. J. Nucl. Med. Mol. Imaging 2022; 49: 2917–2928. Available from: https://pubmed.ncbi.nlm.nih.gov/35230493/.
Liu X, Khalvati F, Namdar K et al. Can machine learning radiomics provide pre‐operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning? Eur. Radiol. 2021; 31: 244–255. Available from: https://pubmed.ncbi.nlm.nih.gov/32749585/.
Stollmayer R, Budai BK, Tóth A et al. Diagnosis of focal liver lesions with deep learning‐based multi‐channel analysis of hepatocyte‐specific contrast‐enhanced magnetic resonance imaging. World J. Gastroenterol. 2021; 27: 5978–5988. Available from: https://pubmed.ncbi.nlm.nih.gov/34629814/.
Zhong X, Guan T, Tang D et al. Differentiation of small (≤ 3 cm) hepatocellular carcinomas from benign nodules in cirrhotic liver: the added additive value of MRI‐based radiomics analysis to LI‐RADS version 2018 algorithm. BMC Gastroenterol. 2021; 21. Available from: https://pubmed.ncbi.nlm.nih.gov/33827440/.
Zhen SH, Cheng M, Tao YB et al. Deep learning for accurate diagnosis of liver tumor based on magnetic resonance imaging and clinical data. Front. Oncol. 2020; 10. Available from: https://pubmed.ncbi.nlm.nih.gov/32547939/.
Jiang H, Liu X, Chen J et al. Man or machine? Prospective comparison of the version 2018 EASL, LI‐RADS criteria and a radiomics model to diagnose hepatocellular carcinoma. Cancer Imaging 2019; 19. Available from: https://pubmed.ncbi.nlm.nih.gov/31806050/.
Wu J, Liu A, Cui J, Chen A, Song Q, Xie L. Radiomics‐based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images. BMC Med. Imaging 2019; 19. Available from: https://pubmed.ncbi.nlm.nih.gov/30866850/.
Hamm CA, Wang CJ, Savic LJ et al. Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi‐phasic MRI. Eur. Radiol. 2019; 29: 3338–3347.
Jansen MJA, Kuijf HJ, Veldhuis WB, Wessels FJ, Viergever MA, Pluim JPW. Automatic classification of focal liver lesions based on MRI and risk factors. PLoS ONE 2019; 14. Available from: https://pubmed.ncbi.nlm.nih.gov/31095624/.
Kiani A, Uyumazturk B, Rajpurkar P et al. Impact of a deep learning assistant on the histopathologic classification of liver cancer. NPJ Digit. Med. 2020; 3. Available from: https://pubmed.ncbi.nlm.nih.gov/32140566/.
Feng S, Yu X, Liang W et al. Development of a deep learning model to assist with diagnosis of hepatocellular carcinoma. Front. Oncol. 2021; 11. Available from: https://pubmed.ncbi.nlm.nih.gov/34926264/.
Cheng B, Zhou P, Chen Y. Machine‐learning algorithms based on personalized pathways for a novel predictive model for the diagnosis of hepatocellular carcinoma. BMC Bioinformatics 2022; 23 Available from: https://pubmed.ncbi.nlm.nih.gov/35739471/.
Sato M, Morimoto K, Kajihara S, Tateishi R, Shiina S, Koike K, Yatomi Y. Machine‐learning approach for the development of a novel predictive model for the diagnosis of hepatocellular carcinoma. Sci. Rep. 2019; 9. Available from: https://pubmed.ncbi.nlm.nih.gov/31147560/
Ghaderzadeh M, Hosseini A, Asadi F, Abolghasemi H, Bashash D, Roshanpoor A. Automated detection model in classification of B‐lymphoblast cells from normal B‐lymphoid precursors in blood smear microscopic images based on the majority voting technique. Sci. Prog. 2022; 2022.
Ghaderzadeh M, Asadi F, Ghorbani NR, Almasi S, Taami T. Toward artificial intelligence (AI) applications in the determination of COVID‐19 infection severity: considering AI as a disease control strategy in future pandemics. Iran. J. Blood Cancer 2023; 15: 93–111. Available from: http://ijbc.ir/article‐1‐1382‐en.html.
Ghaderzadeh M, Eshraghi MA, Asadi F, Hosseini A, Jafari R, Bashash D, Abolghasemi H. Efficient framework for detection of COVID‐19 Omicron and Delta variants based on two intelligent phases of CNN models. Comput. Math. Methods Med. 2022; 2022: 4838009.
Wong GLH, Hui VWK, Tan Q et al. Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis. JHEP Rep. 2022; 4. Available from: https://pubmed.ncbi.nlm.nih.gov/35198928/.
Wong GLH, Yuen PC, Ma AJ, Chan AWH, Leung HHW, Wong VWS. Artificial intelligence in prediction of non‐alcoholic fatty liver disease and fibrosis. J. Gastroenterol. Hepatol. 2021; 36: 543–550. Available from: https://pubmed.ncbi.nlm.nih.gov/33709607/.
Lyu F, Ma AJ, Yip TCF, Wong GLH, Yuen PC. Weakly supervised liver tumor segmentation using Couinaud segment annotation. IEEE Trans. Med. Imaging 2022; 41: 1138–1149. Available from: https://pubmed.ncbi.nlm.nih.gov/34871168/.
Mitrea D, Badea R, Mitrea P, Brad S, Nedevschi S. Hepatocellular carcinoma automatic diagnosis within CEUS and B‐mode ultrasound images using advanced machine learning methods. Sensors (Basel) 2021; 21: 1–31. Available from: https://pubmed.ncbi.nlm.nih.gov/33801125/.
Heimbach JK, Kulik LM, Finn RS et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018; 67: 358–380. Available from: https://pubmed.ncbi.nlm.nih.gov/28130846/.
Pellat A, Barat M, Coriat R, Soyer P, Dohan A. Artificial intelligence: A review of current applications in hepatocellular carcinoma imaging. Diagn. Interv. Imaging 2023; 104: 24–36.
Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology 2016; 278: 563–577. Available from: https://pubmed.ncbi.nlm.nih.gov/26579733/.
Lambin P, Leijenaar RTH, Deist TM et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat. Rev. Clin. Oncol. 2017; 14: 749–762. Available from: https://pubmed.ncbi.nlm.nih.gov/28975929/.